Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
67%(4 trials)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_2
1
17%
Ph phase_1
2
33%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (33.3%)
Phase 21 (16.7%)
N/A3 (50.0%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_1

PRISM Race and Communication Pilot RCT

NCT04915079
completednot_applicable

Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease

NCT04738474
completednot_applicable

The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer

NCT03668223
completedphase_1

Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).

NCT06051448
completednot_applicable

PRISM for Adolescents With Type 1 Diabetes

NCT03847194
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04915079Phase 1

PRISM Race and Communication Pilot RCT

Completed
NCT04738474Not Applicable

Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease

Completed
NCT03668223Not Applicable

The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer

Completed
NCT06051448Phase 1

Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).

Completed
NCT03847194Not Applicable

PRISM for Adolescents With Type 1 Diabetes

Completed
NCT02340884Phase 2

A Pilot RCT of the PRISM Intervention for AYAs With Cancer

Completed

All 6 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
6